Next Catalyst, page-2

  1. 262 Posts.
    lightbulb Created with Sketch.  5
    Agree Orioles. Though I think the deal will be on a PH2b NASH to get the higher dosing tested before a PH3 (& eventual market launch ) Anyway concur. Do you think (on this pharma deal) that it's unreasonable to expect a USD$350mio market cap before the close of 2018?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.